UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One:)      o Form 10-KSB     o Form 20-F      o Form 11-K      x Form 10-QSB       o Form 10-D     o Form N-SAR     o Form N-CSR

  For Period Ended: March 31, 2007

  [   ]     Transition Report on Form 10-K

  [   ]     Transition Report on Form 20-F

  [   ]     Transition Report on Form 11-K

  [   ]     Transition Report on Form 10-Q

  [   ]     Transition Report on Form N-SAR

  For the Transition Period Ended:  

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

THE MEDICAL EXCHANGE, INC.

Full Name of Registrant

N/A

Former Name if Applicable

17 State Street

Address of Principal Executive Office (Street and Number)

New York, New York 10004

City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

x	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
x	(b)	The subject annual report, semi-annual report, transition report on Form 10-KSB, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-QSB, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
¨	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-KSB, 20-F, 11-K, 10-QSB, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The registrant's Quarterly Report on Form 10-QSB for the three months ended March 31, 2007 could not be filed by the prescribed due date because the registrant had not yet finalized its treatment and disclosure of certain material events that occurred during the quarter. The registrant is unable to file such report within the prescribed time period without unreasonable effort or expense. The registrant anticipates that the subject quarterly report will be filed on or before May 21, 2007.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Michael L. Goldberg	212	269-4051
(Name)	(Area Code)	(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ¨ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ¨ Yes x No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

On March 8, 2007, the Registrant acquired (the “Acquisition Transaction”) all of the shares of I.D.O. Security LTD, a privately held company organized under the laws of the State of Israel (“IDO Ltd.”) that is primarily engaged in the design, development and marketing of devices for the homeland security market. Following the consummation of the Acquisition Transaction, IDO Ltd. became a wholly-owned subsidiary of the Registrant.

For the three months ended March 31, 2007, the registrant currently estimates that it had revenues of approximately $20,000. As of the date below, the Registrant is unable to estimate its net loss for the period. Results for the 2007 period remain subject to further adjustment. The estimated revenues and net loss for the three month period ended March 31, 2007 include the activities of IDO Ltd.

This Notification of Late Filing on Form 12b-25 contains forward-looking statements, including forward-looking statements relating to the Registrant's financial results for the quarter ended March 31, 2007. These statements are based on management's current expectations and involve a number of risks and uncertainties, including risks described in our filings with the Securities and Exchange Commission. The Registrant's actual results may differ materially from the Registrant's anticipated or expected results and the results in the forward-looking statements.

THE MEDICAL EXCHANGE, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	May 15, 2007	/s/ Michael L. Goldberg
		Michael L. Goldberg
		Acting Chief Executive Officer (Principal Executive Officer)